
TREXIMET 85-500 MG TABLET GLAXOSMITHKLINE Approx. Price: $206.65 per 9Each
All Labeled Uses: Migraine
TREXIMET contains sumatriptan (as the succinate), a selective 5-hydroxytryptamine1 (5-HT1) receptor subtype agonist, and naproxen sodium, a member of the arylacetic acid group of nonsteroidal anti-inflammatory drugs (NSAIDs).Drug-Drug Interactions
![]()
Clearly contraindicated in all cases and should not be dispensed or administered to the same patient:
5HT-1D AGONISTS/ERGOTAMINES; METHYSERGIDE -
SELECTED 5HT-1D AGONISTS/MAO INHIBITORS - Adverse reaction of the former drug
SELECTED NEPHROTOXIC AGENTS/CIDOFOVIR - Adverse reaction with both drugs
SEROTONINERGIC AGENTS/SIBUTRAMINE - Adverse reaction of the latter drug
NSAID;ASPIRIN/KETOROLAC - Adverse reaction with both drugs
SEROTONINERGIC AGENTS/DEXFENFLURAMINE; FENFLURAMINE - Adverse reaction with both drugs
Severe Interaction:
Action is required to reduce the risk of severe adverse interaction.
LONG HALF-LIFE NSAIDS; DIFLUNISAL/PEMETREXED -
NSAIDS/METHOTREXATE - Increased effect of the latter drug
Moderate Interaction:
Assess the risk to the patient and take action as needed.
NSAIDS/LOOP DIURETICS - Decreased effect of the latter drug
NSAIDS/LITHIUM - Increased effect of the latter drug
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS/BETA-BLOCKERS - Decreased effect of the latter drug
5HT-1D AGONISTS/SSRI’S; SNRI’S - Adverse reaction of the latter drug
SELECTED NSAIDS/PROBENECID - Increased effect of the former drug
NSAIDS/TENOFOVIR - Additive side effects from both drugs
NSAIDS/DROSPIRENONE - Additive side effects from both drugs
NSAIDS; ASPIRIN/SSRI’S; SNRI’S - Adverse reaction with both drugs
NSAIDS/SELECTED PLATELET AGGREGATION INHIBITORS - Additive side effects from both drugs
NSAIDS/HEPARINS - Additive side effects from both drugs
NSAIDS/ANTICOAGULANTS - Increased effect of the latter drug
NSAIDS/TRIAMTERENE; AMILORIDE - Adverse reaction of the latter drug
NSAIDS/CYCLOSPORINE - Adverse reaction with both drugs
SELECTED NSAIDS/ACE INHIBITORS; ARB’S - Decreased effect of the latter drug
| Label Warnings |
Warning: SAFETY & EFFICACY NOT ESTABLISHED IN CHILDREN LESS THAN 2 YRS
Relative Contraindication: SAFETY AND EFFICACY NOT ESTABLISHED. NOT RECOMMENDED BY MANUFACTURER.
Lactation
Precaution: AMERICAN ACAD OF PEDIATRICS(AAP) CONSIDERS DRUG COMPATIBLE WITH BREASTFEEDING
Precaution: AMER ACAD PEDS CONSIDERS DRUG COMPATIBLE W BREASTFEEDING. MFR RECOMM CAUTION.
Pregnancy
FDB Contraindicated or Not Recommended: FDA CAT C. NOT RECOM,RISK OF PREMATURE CLOSURE OF DUCT ARTERIOSUS,MISCARRIAGE
Only When Necessary
Geriatric
Contraindication: NOT RECOMMENDED: INCREASED CV RISK FACTORS; INCREASED EFFECTS ON BP
Precaution: (SOM)(BEERS02)RISK OF SERIOUS/FATAL GI BLEED,ULCER; CV/RENAL ADV.EFX
| Adverse Effects |
Most Frequent:
Abdominal Pain with Cramps, Body Fluid Retention, Constipation, Dizziness, Drowsy, Edema, Headache Disorder, Heartburn, Nausea, Skin Rash, Tinnitus, Urticaria













